Clinical Significance of the Resistance Proteins LRP, Pgp, MRP1, MRP3, and MRP5 in Epithelial Ovarian Cancer
- 1 February 2015
- journal article
- research article
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 25 (2) , 236-243
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Conservation of in vitro drug resistance patterns in epithelial ovarian carcinomaGynecologic Oncology, 2005
- The Role of ABC Transporters in Drug Resistance, Metabolism and ToxicityCurrent Drug Delivery, 2004
- Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2002
- Recent Advancements in the Treatment of Epithelial Ovarian Cancer*Journal of Obstetrics and Gynaecology Research, 2001
- P-glycoprotein and multidrug resistanceCurrent Opinion in Genetics & Development, 1996
- Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell LineScience, 1992
- ABC Transporters: From Microorganisms to ManAnnual Review of Cell Biology, 1992
- Amplification of DNA sequences in human multidrug-resistant KB carcinoma cells.Proceedings of the National Academy of Sciences, 1985
- A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutantsBiochimica et Biophysica Acta (BBA) - Biomembranes, 1976
- Reduced permeability in CHO cells as a mechanism of resistance to colchicineJournal of Cellular Physiology, 1974